Table 4.

Comparison ofbefore group patient and clinician medication changes

Variable	Patient changes (before group)	Clinician changes (before group)	p-value
Number of patients who made or received changes	29 (80.6%)	20 (55.6%)	.021*
Average number per patient	2.75 (2.73)	2.28 (2.70)	.140
Additions	1.36 (2.52)	1.06 (2.33)	.546
Deletions	1.14 (1.42)	1.11 (1.56)	.539
Modifications	0.25 (0.87)	0.11 (0.32)	.245
Average potential severity	1.09 (0.69)	1.10 (0.62)	.570
Potential severity			.662
Level 0 (insignificant)	20 (21.1%)	15 (18.5%)
Level 1 (significant)	59 (62.1%)	57 (70.4%)
Level 2 (serious)	14 (14.7%)	8 (9.9%)
Level 3 (life-threatening)	2 (2.1%)	1 (1.2%)
Average potential harm	3.38 (1.37)	3.62 (1.22)	.902
Potential harm			.576
Level 1 (little or no confidence)	16 (16.8%)	9 (11.1%)
Level 2 (slight to modest confidence)	14 (14.7%)	8 (9.9%)
Level 3 (< 50–50 but close call)	14 (14.7%)	11 (13.6%)
Level 4 (> 50–50 but close call)	39 (41.1%)	44 (54.3%)
Level 5 (strong confidence)	8 (8.4%)	7 (8.6%)
Level 6 (virtually certain confidence)	4 (4.2%)	2 (2.5%)

Number of patients reported as n (%); averages reported as mean (SD), categorical variables reported as n (%).

Percentages adjusted to account for missing data.

^*p-value significant at the .05 level.